Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Elevance Health Stands by 2024 Forecast with Strong Financial Results

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Healthcare-sector
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Elevance Health is standing by its forecast for 2024, projecting a net income of over $34.29 per diluted share and more than $37.10 on an adjusted basis, surpassing the anticipated $37.05.

The company delivered impressive financial results in the final quarter of 2023, recording operating revenue of $42.5 billion, a 7.0% rise from the prior year. Their GAAP diluted EPS also saw growth, reaching $3.63, up 1.1% from the same period in 2022. Looking ahead to 2024, Elevance Health expects total operating revenue to remain steady or experience slight growth.

In Q4 of 2023, Elevance Health achieved a net income of $856 million, with total revenues climbing to $42.6 billion, marking a 6.8% increase year over year. While the company’s adjusted profit for the quarter fell slightly short of Wall Street’s projections, Elevance Health remains confident in surpassing profit expectations for the full year of 2024.

On March 4, 2024, Elevance Health reaffirms its strong financial standing and optimistic outlook for the future.

ELV Stock Price Update: March 4, 2024 – Minor Decline with Strong Price Momentum

On March 4, 2024, ELV stock experienced a slight decrease in its price, closing at $499.11. This represents a $2.14 drop from the previous market close, translating to a 0.43% decrease in value. Despite this minor decline, ELV is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum.

After the market closed, ELV stock remained unchanged in after-hours trading, suggesting that investors may be holding steady on their positions. This stability could be a result of market participants taking a wait-and-see approach, possibly awaiting more information or developments before making any significant moves.

Investors should conduct thorough research and analysis before making any investment decisions. ELV’s performance on March 4, 2024, reflects a slight decrease in price but with strong price momentum overall. Investors should continue to monitor the stock’s performance and stay informed of any relevant news or updates that may impact its value in the future.

ELV Stock Performance Analysis: Revenue Increases, Net Income Holds Flat

On March 4, 2024, ELV stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was $171.34 billion over the past year, with $42.65 billion generated in the fourth quarter. This represents a 9.42% increase in total revenue since the previous year, but total revenue held flat compared to the previous quarter.

Net income for ELV was reported at $5.99 billion for the year and $856 million for the fourth quarter. The net income remained flat compared to the previous year and also held flat compared to the previous quarter.

Earnings per share (EPS) for ELV were $25.22 for the year and $3.63 for the fourth quarter. The EPS also remained flat compared to the previous year and held flat compared to the previous quarter.

Tags: ELV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Promising Results from Akero Therapeutics Efruxifermin Trial for PreCirrhotic NASH

Fiances and technology

Exploring the IP Range 664276024 Insights and Information Services

Home Construction Stock Market Today

United Rentals Acquires Yak Access for 11 Billion A Strategic Move for Market Dominance

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com